Observational Study on Endometrial Stromal Tumors
ConditionEndometrial Stromal Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-80
SponsorItalian Sarcoma Group
About this trial
Observational, retrospective and prospective study on Endometrial Stromal Tumor (EST)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients with a diagnosis of Endometrial Stromal Tumor (EST) according to the World Health Organization (WHO) classification 2003 or 2014
Informed consent signature
Disqualifiers
patients with different diagnosis from EST
Trial population
All the patients with a diagnosis of Endometrial Stromal Tumor (EST)
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Treatment for EST
Other interventionSurgery and/or Chemotherapy and or/radiotherapy for EST treatment according to disease guidelines: no specific treatment is imposed by protocol (observational study)
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Retrospective Observational Group1 intervention
Group B: Prospective Observational Group1 intervention
Trial outcomes
Primary outcomes
1
Disease natural history
Collection of data on the natural history of endometrial stromal tumors
Time frame
Through survival, an average of 5 yearsSecondary outcomes
1
Disease diagnosis and classification
Highlight some main issues in pathologic diagnosis of these tumors and their classification
Time frame
At the time of diagnosis, an average of 1 month2
Chemotherapy received treatment
Number and type of chemotherapy agents received for EST treatment
Time frame
Through treatment completion, an average of 24 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov